Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Growth Hormone in Chronic Heart Failure
NCT00501514Phase 3Completed
- Sponsor
- University of Naples Federico II
- Start
- Nov 1997
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic heart failure (CHF) comparing Growth Hormone with Placebo (2 arms). Primary endpoint: Peak Oxygen Consumption at 3 months. Started Nov 1997; status: completed.
02
Drugs
somatropin
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00501514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00501514.